arrow
J

Jijun Wang

Shanghai Jiaotong University School of Medicine
H指数:47
被引数:9,214

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Unraveling Suicidal Ideation and Behaviors in a Global Cohort of Individuals at Clinical High-Risk for Psychosis: Multivariable Correlates and Subthreshold Psychotic Symptoms

揭示全球临床高风险精神分裂症个体中的自杀意念与行为:多变量相关因素和阈下精神病症状

2026-09-130
OAAI
Effectiveness of magnetic seizure therapy versus electroconvulsive therapy for major depressive episode in China: protocol for a double-blind; randomized; non-inferiority trial

中国重大抑郁发作中磁性惊厥疗法与电休克疗法的疗效:一项双盲、随机、非劣效性试验方案

2025-10-230
OAAI
Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative

收集语言、语音声学和面部表情数据以预测精神分裂症及其他临床结果:AMP® SCZ倡议的策略

2025-10-150
OAAI
The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures

加速药品合作计划®精神分裂症项目中的脑电图协议:测量指标的可靠性与稳定性

2025-06-060
OAAI
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program

加速药物合作®精神分裂症计划中的数字健康技术

2025-06-030
OAAI
Early improvement of psychopathological symptoms with add-on repetitive transcranial magnetic stimulation treatment as the key contributor to improving remission in schizophrenia

精神病理症状的早期改善与附加重复经颅磁刺激治疗作为改善精神分裂症缓解的关键贡献因素。

2025-05-230
PRE
The impact of aripiprazole on neurocognitive function in individuals at clinical high risk for psychosis: A comparison with olanzapine and non-antipsychotic treatment

曾, J.; Raballo, A.; 叶, J.; Gao, Y.; Su, W.; Wei, Y.; Tang, X.; Xu, L.; Hu, Y.; 张, D.; 等. 阿立哌唑对临床高风险精神病个体神经认知功能的影响:与奥氮平和非抗精神病药物治疗的比较. Eur. Psychiatry 2025, 68, e69. [Google Scholar] [CrossRef]

2025-05-222
OAAI
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample

加速药物伙伴关系中的认知评估®精神分裂症计划: 在不同的国际样本中协调优先事项和策略

2025-03-240
OAAI